PJS-539
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PJS-539, covering 2022-04-12 to 2022-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of PJS-539 for Adult Patients With COVID-19. [Phase 2]